Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

People with TED often have low B12 levels and might benefit from B12 supplements.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Wolvit® (biotin 5 mg) is effective and safe for treating hair loss and scalp conditions in women.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

Low iron and vitamin D3 levels might be major causes of hair loss in Iraqi women.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

COVID-19 can cause temporary hair loss.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

Telogen Effluvium causes more hair loss because hair moves to the resting phase too soon.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.